Texas Society of Clinical Oncology (TxSCO) 2022 Annual Conference - Friday, October 21 – Saturday, October 22, 2022

Houston, TX US

Target Audience

Physicians, Pharmacists, Physician Assistants, Nurses, and Nurse Practitioners who are interested in the field of Oncology

Learning Objectives

At the end of this educational activity, participants should be able to: 

  1. Summarize recent advances in the management of various cancers, such as HER2-positive breast cancer, diffuse large B-cell lymphoma, and gastrointestinal malignancies. 
  2. Describe clear, brown, and white bagging and the strategies to navigate these insurer-mandated practices for dispensing medications.  
  3. Discuss barriers to care for underserved populations, including social determinants of health, and their role in overcoming these barriers.  
  4. Define value-based care. 
  5. Evaluate how their practice can benefit from participating in value-based care and quality programs, such as the Centers for Medicare & Medicaid Service’s Enhancing Oncology Model. 
Course summary
Available credit: 
  • 5.75 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 5.75 ANCC
    • 3.00 ANCC Pharmacology
  • 5.75 Participation
Course opens: 
10/21/2022
Course expires: 
10/22/2023
Rating: 
0
JW Marriott
806 Main St
Houston, TX 77002
United States
+1 (713) 237-1111
https://www.marriott.com/en-us/hotels/houdj-jw-marriott-houston-downtown/overvie…

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the Texas Society of Clinical Oncology.

Boston University School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the Texas Society of Clinical Oncology.

Contact Hours: 5.75, of which 3.00 is pharmacology credit worthy

Available Credit

  • 5.75 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 5.75 ANCC
    • 3.00 ANCC Pharmacology
  • 5.75 Participation
Please login or register to take this course.